Cargando…

Practical guide to exocrine pancreatic insufficiency – Breaking the myths

BACKGROUND: Exocrine pancreatic insufficiency (EPI) is characterized by a deficiency of exocrine pancreatic enzymes, resulting in malabsorption. Numerous conditions account for the etiology of EPI, with the most common being diseases of the pancreatic parenchyma including chronic pancreatitis, cysti...

Descripción completa

Detalles Bibliográficos
Autores principales: Struyvenberg, Maarten R., Martin, Camilia R., Freedman, Steven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301368/
https://www.ncbi.nlm.nih.gov/pubmed/28183317
http://dx.doi.org/10.1186/s12916-017-0783-y
_version_ 1782506350699347968
author Struyvenberg, Maarten R.
Martin, Camilia R.
Freedman, Steven D.
author_facet Struyvenberg, Maarten R.
Martin, Camilia R.
Freedman, Steven D.
author_sort Struyvenberg, Maarten R.
collection PubMed
description BACKGROUND: Exocrine pancreatic insufficiency (EPI) is characterized by a deficiency of exocrine pancreatic enzymes, resulting in malabsorption. Numerous conditions account for the etiology of EPI, with the most common being diseases of the pancreatic parenchyma including chronic pancreatitis, cystic fibrosis, and a history of extensive necrotizing acute pancreatitis. Treatment for EPI includes dietary management, lifestyle changes (i.e., decrease in alcohol consumption and smoking cessation), and pancreatic enzyme replacement therapy. DISCUSSION: Many diagnostic tests are available to diagnose EPI, however, the criteria of choice remain unclear and the causes for a false-positive test are not yet understood. Despite multiple studies on the treatment of EPI using exogenous pancreatic enzymes, there remains confusion amongst medical practitioners with regard to the best approach to diagnose EPI, as well as dosing and administration of pancreatic enzymes. SUMMARY: Appropriate use of diagnostics and treatment approaches using pancreatic enzymes in EPI is essential for patients. This opinion piece aims to address the existing myths, remove the current confusion, and function as a practical guide to the diagnosis and treatment of EPI.
format Online
Article
Text
id pubmed-5301368
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53013682017-02-15 Practical guide to exocrine pancreatic insufficiency – Breaking the myths Struyvenberg, Maarten R. Martin, Camilia R. Freedman, Steven D. BMC Med Opinion BACKGROUND: Exocrine pancreatic insufficiency (EPI) is characterized by a deficiency of exocrine pancreatic enzymes, resulting in malabsorption. Numerous conditions account for the etiology of EPI, with the most common being diseases of the pancreatic parenchyma including chronic pancreatitis, cystic fibrosis, and a history of extensive necrotizing acute pancreatitis. Treatment for EPI includes dietary management, lifestyle changes (i.e., decrease in alcohol consumption and smoking cessation), and pancreatic enzyme replacement therapy. DISCUSSION: Many diagnostic tests are available to diagnose EPI, however, the criteria of choice remain unclear and the causes for a false-positive test are not yet understood. Despite multiple studies on the treatment of EPI using exogenous pancreatic enzymes, there remains confusion amongst medical practitioners with regard to the best approach to diagnose EPI, as well as dosing and administration of pancreatic enzymes. SUMMARY: Appropriate use of diagnostics and treatment approaches using pancreatic enzymes in EPI is essential for patients. This opinion piece aims to address the existing myths, remove the current confusion, and function as a practical guide to the diagnosis and treatment of EPI. BioMed Central 2017-02-10 /pmc/articles/PMC5301368/ /pubmed/28183317 http://dx.doi.org/10.1186/s12916-017-0783-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
Struyvenberg, Maarten R.
Martin, Camilia R.
Freedman, Steven D.
Practical guide to exocrine pancreatic insufficiency – Breaking the myths
title Practical guide to exocrine pancreatic insufficiency – Breaking the myths
title_full Practical guide to exocrine pancreatic insufficiency – Breaking the myths
title_fullStr Practical guide to exocrine pancreatic insufficiency – Breaking the myths
title_full_unstemmed Practical guide to exocrine pancreatic insufficiency – Breaking the myths
title_short Practical guide to exocrine pancreatic insufficiency – Breaking the myths
title_sort practical guide to exocrine pancreatic insufficiency – breaking the myths
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301368/
https://www.ncbi.nlm.nih.gov/pubmed/28183317
http://dx.doi.org/10.1186/s12916-017-0783-y
work_keys_str_mv AT struyvenbergmaartenr practicalguidetoexocrinepancreaticinsufficiencybreakingthemyths
AT martincamiliar practicalguidetoexocrinepancreaticinsufficiencybreakingthemyths
AT freedmanstevend practicalguidetoexocrinepancreaticinsufficiencybreakingthemyths